Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04591106 · ClinicalTrials.gov registry record
Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE
A clinical trial of NASH - Nonalcoholic Steatohepatitis and NAFLD, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 135
- Enrollment target
- 1
- Study location
NCT04591106 is a study of NASH - Nonalcoholic Steatohepatitis and NAFLD that has completed, run by University of California, Los Angeles. The registered enrollment target is 135 participants, below the 264-participant average among 27 other NASH - Nonalcoholic Steatohepatitis trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04591106, a study of NASH - Nonalcoholic Steatohepatitis and NAFLD, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 135 participants
- Enrollment target
- 1
- Study location
Study Summary
Magnetic resonance imaging (MRI) is used to measure liver fat content and fatty tissues in the body, and magnetic resonance elastography (MRE) is used to measure liver stiffness. The information from MRI and MRE are used to understand risk factors and diagnose liver diseases, such as fatty liver disease and liver fibrosis. However, current MRI and MRE scans need to be performed during a breath-hold, which may be challenging or impossible in children and infants. The goal of this research project is to develop and evaluate new free-breathing MRI and MRE technology to improve the comfort and diagnostic accuracy for children and infants.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Magnetic resonance imaging (MRI)
- DIAGNOSTIC_TEST Magnetic resonance elastography (MRE)
- DEVICE Prototype MRE soft flexible passive transducer paddle
Study Locations (1)
California
- UCLA Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2021-02-17 |
| Est. Completion | 2026-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04591106
The ClinicalTrials.gov registry entry for NCT04591106 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 264-participant average among 27 other NASH - Nonalcoholic Steatohepatitis trials with a reported enrollment target (49% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with NASH - Nonalcoholic Steatohepatitis appearing as the primary indexed condition, and to 3 interventions - of which Magnetic resonance imaging (MRI) is the first listed.
NCT04591106 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04591106 about?
NCT04591106 is a clinical study titled "Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE". Magnetic resonance imaging (MRI) is used to measure liver fat content and fatty tissues in the body, and magnetic resonance elastography (MRE) is used to measure liver stiffness. The information from MRI and MRE are used to understand risk factors and diagnose liver diseases, such as fatty liver dis...
What is the current status of trial NCT04591106?
This trial is currently completed. The enrollment target is 135 participants. The study started on 2021-02-17. Estimated completion is 2026-02-28.
What conditions does trial NCT04591106 study?
This clinical trial studies the following conditions: NASH - Nonalcoholic Steatohepatitis, NAFLD.
What interventions are being tested in trial NCT04591106?
The interventions under investigation include: Magnetic resonance imaging (MRI) (DIAGNOSTIC_TEST), Magnetic resonance elastography (MRE) (DIAGNOSTIC_TEST), Prototype MRE soft flexible passive transducer paddle (DEVICE).
Who is sponsoring clinical trial NCT04591106?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04591106 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NASH - Nonalcoholic Steatohepatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
RECRUITING
-
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
RECRUITING · NA
-
Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis
RECRUITING · NA
-
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
RECRUITING · Phase 3
-
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
RECRUITING · Phase 3
-
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.